The diagnosis and treatments of Attention Deficit Hyperactivity Disorder (ADHD), which is characterized by patterns of inattention, hyperactivity, and impulsivity that inhibit an individual’s ability to complete daily tasks or functions, have increased dramatically in recent years. Stimulant drugs such as Ritalin and Adderall are the most common forms of prescribed treatment for ADHD across all age groups. Although these drugs are frequently used to treat symptoms and enhance concentration in people with ADHD, the amount of knowledge on their long-term and developmental effects on the human body and mind is lackluster. Even though previous studies have thoroughly documented short-term side effects, qualitative and quantitative studies on the long-term consequences of these medications are lacking or nonexistent. Given that more than six million children in the US alone are diagnosed with ADHD, proving the issue to be urgent, the question arises: why is there so little research on the extended use of these medications? Knowing the long-term effects of these medications is crucial for both public health and well-informed medical practice, as the number of people receiving ADHD medication is rising. Although previous research offers an adequate foundation for comprehending the short-term advantages and disadvantages of ADHD drugs such as Adderall, the emphasis on the short-term effects leaves significant knowledge gaps regarding their long-term effects. It is crucial to look into how these drugs impact people over lengthy periods because they are widely used and frequently taken for the rest of one's life. Therefore, a more thorough, long-term study is required to determine the exact impact of sustained ADHD drug use to promote informed decision-making and protect patient health.

For several reasons, the absence of long-term research is concerning. First off, according to the Centers for Disease Control and Prevention (CDC), more than seven million children in the US alone have been diagnosed with ADHD, making the condition very common in that age group specifically (roughly 11.4% of children 3-17 years of age). Many of these children are given stimulant medicine at a young age, and some of them continue treatment into adulthood. These individuals could be at risk for unanticipated health effects as a result of this extended exposure to the medicines due to the lack of full awareness of the long-term risks that coincide with being administered medicine like Adderal in the developmental stage of life. Second, there are concerns regarding the long-term repercussions of the immediate adverse effects that ADHD drugs can produce, such as elevated heart rate, appetite suppression, and insomnia. What could years of use involve if such noticeable changes in the body can be brought about by short-term use? Due to the scarcity of evidence-based research on this topic, patients, parents, and medical professionals are left in the dark and unable to make well-informed judgments regarding long-term medication use.

Despite the widespread usage of stimulants like Adderall and Ritalin, there is not nearly enough evidence-based research that explores the long-term and adverse effects of the medications. As a result, critical questions are left unanswered, and significant gaps in the knowledge hinder the ability for informed decision-making for both healthcare professionals and patients. Other than the facts on the short-term effectiveness of these medications and their potential risks, the long-term consequences of prolonged use remain unknown. Research on this topic has made it vividly clear that this is true, with researchers and experts emphasizing the necessity of comprehensive studies to be performed on the safety and efficacy of stimulant medications. The knowledge surrounding psychotropic drugs and their long-term safety profiles, which include stimulant ADHD medication, is “at best incomplete and in some cases non-existent” (Recalt 39). This statement and overall incomplete understanding is alarming given the vast amount of individuals being or already prescribed these medications that nobody is sure are safe in the long term. More uncertainty arises as possible problems appear that were not discovered until the present moment.